GANTRISIN Overview
SULFISOXAZOLE
- TABLET; ORAL: 500MG
- INJECTABLE; INJECTION: EQ 400MG BASE/ML
- SOLUTION/DROPS; OPHTHALMIC: EQ 4% BASE
- OINTMENT; OPHTHALMIC: EQ 4% BASE
- SYRUP; ORAL: EQ 500MG BASE/5ML
Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).
| FDA application | Dosage Form | Strength | Marketing Status | Company |
|---|---|---|---|---|
| NDA #006525 | TABLET; ORAL | 500MG | Discontinued | ROCHE |
| NDA #006917 | INJECTABLE; INJECTION | EQ 400MG BASE/ML | Discontinued | ROCHE |
| NDA #007757 | SOLUTION/DROPS; OPHTHALMIC | EQ 4% BASE | Discontinued | ROCHE |
| NDA #008414 | OINTMENT; OPHTHALMIC | EQ 4% BASE | Discontinued | ROCHE |
| NDA #009182 | SYRUP; ORAL | EQ 500MG BASE/5ML | Discontinued | ROCHE |
